Cases reported "Proteus Infections"

Filter by keywords:



Filtering documents. Please wait...

1/5. Nephrobronchial fistula secondary to xantogranulomatous pyelonephritis.

    We report a case of staghorn nephrolithiasis that evolved into xanthogranulomatous pyelonephritis with perinephric abscess, nephrobronchial fistula, and lung abscess. The patient was an intravenous drug abuser who tested positive for human immunodeficiency virus, without evidence of acquired immunodeficiency syndrome. He presented with a 2-month history of untreated repeated episodes of left flank pain and hyperpyrexia. Treatment involved left nephrectomy, debridement of abscess, tube drainage, and intravenous antibiotics. The patient illustrates the need to consider untreated nephrolitiasis as a predisposing factor for pulmonary complications.
- - - - - - - - - -
ranking = 1
keywords = pyelonephritis
(Clic here for more details about this article)

2/5. Xanthogranulomatous pyelonephritis masquerading as occult malignancy.

    Xanthogranulomatous pyelonephritis (XGP) can present with weight loss, anemia, leukemoid reaction, and generalized debility; there may be no signs or symptoms referable to the urinary tract. confusion between XGP and renal adenocarcinoma is well recognized, but other malignancies can also be simulated. Case histories of patients with proved XGP whose clinical presentations suggested occult malignancies are recorded. proteus urinary tract infection, calculi, and a nonvisualizing kidney on intravenous pyelogram should suggest the correct diagnosis. The pathology, bacteriology, diagnosis, and treatment are reviewed.
- - - - - - - - - -
ranking = 1
keywords = pyelonephritis
(Clic here for more details about this article)

3/5. Computed tomography of xanthogranulomatous pyelonephritis presenting as a flank mass.

    Xanthogranulomatous pyelonephritis should be part of the differential diagnosis when extensive soft tissue involvement is associated with renal disease. As a diagnosis of neoplasm may be rendered even on microscopy, it is particularly important that this entity be considered.
- - - - - - - - - -
ranking = 1
keywords = pyelonephritis
(Clic here for more details about this article)

4/5. Clinical and laboratory study of tobramycin in the treatment of infections due to gram-negative organisms.

    tobramycin, an aminoglycoside antibiotic, was used to treat 52 infections due to gram-negative organisms in 51 patients. Complicated urinary tract infections, bacteremia and pyelonephritis accounted for 80% of the infections. The rate of immediate satisfactory response was 79%. During therapy with tobramycin, resistant organisms emerged in four patients--two pseudomonas aeruginosa and two escherichia coli strains. There were four superinfections with tobramycin-resistant providencia sp. In four seriously ill patients the serum creatinine concentration increased 1 mg/dL or more; in three the increase was transient. No auditory toxicity was noted in the 19 patients in whom serial audiograms were made. in vitro testing of isolates from these patients showed that tobramycin and gentamicin had equal activity against enterobacteriaceae. tobramycin was two to four times more active against susceptible P. aeruginosa.
- - - - - - - - - -
ranking = 0.2
keywords = pyelonephritis
(Clic here for more details about this article)

5/5. Paediatric xanthogranulomatous pyelonephritis.

    Xanthogranulomatous pyelonephritis (XGP) is a well recognised but rare type of chronic pyelonephritis classically occurring in middle-aged women. It is increasingly being recognised in children in whom it can be mistaken for Wilms' tumour. awareness of the possibility of this condition occurring in children may allow early recognition and possible treatment. Two cases of XGP in children are described and the literature reviewed.
- - - - - - - - - -
ranking = 1.2
keywords = pyelonephritis
(Clic here for more details about this article)


Leave a message about 'Proteus Infections'


We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.